(2026) Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
To understand how this evolving market might play out, this paper will address the following questions: What is the current state of the incretin mimetic market in diabetes and obesity, and how did we get here
Possible clues include fatigue, exercise intolerance, cognitive variability, poor recovery after infection, worsening with fasting, muscle weakness or regression during metabolic stress
Spirits with Low-Calorie Mixers Choose soda water or diet tonic instead of sugary sodas
Vitamin B12 injections, typically hydroxocobalamin as recommended by NICE and the BNF, are prescribed for documented deficiency or malabsorption conditions rather than as general energy boosters